Aslan Cost Of Revenue from 2010 to 2024
| ASLN Stock | USD 0.51 0.01 1.06% |
Cost Of Revenue | First Reported 2016-12-31 | Previous Quarter 0.0 | Current Value 0.0 | Quarterly Volatility 31.3 K |
Check Aslan Pharmaceuticals financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Aslan main balance sheet or income statement drivers, such as Discontinued Operations of 0.0, Depreciation And Amortization of 398.2 K or Interest Expense of 5 M, as well as many exotic indicators such as Price To Sales Ratio of 0.78, Dividend Yield of 0.0 or Days Sales Outstanding of 5.7. Aslan financial statements analysis is a perfect complement when working with Aslan Pharmaceuticals Valuation or Volatility modules.
Aslan | Cost Of Revenue |
Latest Aslan Pharmaceuticals' Cost Of Revenue Growth Pattern
Below is the plot of the Cost Of Revenue of Aslan Pharmaceuticals Ltd over the last few years. Cost of Revenue is found on Aslan Pharmaceuticals income statement and represents the costs associated with goods and services Aslan Pharmaceuticals provides. Indirect cost, such as salaries, is not included. In other words, cost of revenue is the total cost incurred to obtain a sale. It is more than the traditional cost of goods sold, since it includes specific selling and marketing activities. It is Aslan Pharmaceuticals' Cost Of Revenue historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Aslan Pharmaceuticals' overall financial position and show how it may be relating to other accounts over time.
| Cost Of Revenue | 10 Years Trend |
|
Cost Of Revenue |
| Timeline |
Aslan Cost Of Revenue Regression Statistics
| Arithmetic Mean | 132,598 | |
| Geometric Mean | 0.00 | |
| Coefficient Of Variation | 120.31 | |
| Mean Deviation | 142,535 | |
| Median | 0.00 | |
| Standard Deviation | 159,523 | |
| Sample Variance | 25.4B | |
| Range | 407.3K | |
| R-Value | 0.79 | |
| Mean Square Error | 10.5B | |
| R-Squared | 0.62 | |
| Significance | 0.0005 | |
| Slope | 28,006 | |
| Total Sum of Squares | 356.3B |
Aslan Cost Of Revenue History
About Aslan Pharmaceuticals Financial Statements
There are typically three primary documents that fall into the category of financial statements. These documents include Aslan Pharmaceuticals income statement, its balance sheet, and the statement of cash flows. Aslan Pharmaceuticals investors use historical funamental indicators, such as Aslan Pharmaceuticals's Cost Of Revenue, to determine how well the company is positioned to perform in the future. Although Aslan Pharmaceuticals investors may use each financial statement separately, they are all related. The changes in Aslan Pharmaceuticals's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Aslan Pharmaceuticals's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Aslan Pharmaceuticals Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Aslan Pharmaceuticals. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Cost Of Revenue | 348.5 K | 197.1 K |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Aslan Pharmaceuticals in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Aslan Pharmaceuticals' short interest history, or implied volatility extrapolated from Aslan Pharmaceuticals options trading.
Pair Trading with Aslan Pharmaceuticals
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Aslan Pharmaceuticals position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Aslan Pharmaceuticals will appreciate offsetting losses from the drop in the long position's value.The ability to find closely correlated positions to Aslan Pharmaceuticals could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Aslan Pharmaceuticals when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Aslan Pharmaceuticals - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Aslan Pharmaceuticals Ltd to buy it.
The correlation of Aslan Pharmaceuticals is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Aslan Pharmaceuticals moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Aslan Pharmaceuticals moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Aslan Pharmaceuticals can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out the analysis of Aslan Pharmaceuticals Correlation against competitors. You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.
Complementary Tools for Aslan Stock analysis
When running Aslan Pharmaceuticals' price analysis, check to measure Aslan Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Aslan Pharmaceuticals is operating at the current time. Most of Aslan Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Aslan Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Aslan Pharmaceuticals' price. Additionally, you may evaluate how the addition of Aslan Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites |
Is Aslan Pharmaceuticals' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Aslan Pharmaceuticals. If investors know Aslan will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Aslan Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (3.00) | Revenue Per Share 0.746 | Return On Assets (0.64) | Return On Equity (4.27) |
The market value of Aslan Pharmaceuticals is measured differently than its book value, which is the value of Aslan that is recorded on the company's balance sheet. Investors also form their own opinion of Aslan Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Aslan Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Aslan Pharmaceuticals' market value can be influenced by many factors that don't directly affect Aslan Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Aslan Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Aslan Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Aslan Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.